- Home
- CPIX vs VTVT Comparison
CPIX vs VTVT Comparison
Compare CPIX & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- VTVT
- Stock Information
- Founded
- CPIX 1999
- VTVT 2015
- Country
- CPIX United States
- VTVT United States
- Employees
- CPIX N/A
- VTVT N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- VTVT Health Care
- Exchange
- CPIX Nasdaq
- VTVT Nasdaq
- Market Cap
- CPIX 48.5M
- VTVT 47.9M
- IPO Year
- CPIX 2009
- VTVT 2015
- Fundamental
- Price
- CPIX $3.23
- VTVT $21.03
- Analyst Decision
- CPIX
- VTVT Strong Buy
- Analyst Count
- CPIX 0
- VTVT 2
- Target Price
- CPIX N/A
- VTVT $35.50
- AVG Volume (30 Days)
- CPIX 32.7K
- VTVT 3.4K
- Earning Date
- CPIX 11-06-2025
- VTVT 11-11-2025
- Dividend Yield
- CPIX N/A
- VTVT N/A
- EPS Growth
- CPIX N/A
- VTVT N/A
- EPS
- CPIX N/A
- VTVT N/A
- Revenue
- CPIX $42,071,813.00
- VTVT $17,000.00
- Revenue This Year
- CPIX N/A
- VTVT N/A
- Revenue Next Year
- CPIX N/A
- VTVT N/A
- P/E Ratio
- CPIX N/A
- VTVT N/A
- Revenue Growth
- CPIX 11.34
- VTVT N/A
- 52 Week Low
- CPIX $1.04
- VTVT $12.62
- 52 Week High
- CPIX $7.25
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- CPIX 43.51
- VTVT 75.87
- Support Level
- CPIX $3.26
- VTVT $19.15
- Resistance Level
- CPIX $3.57
- VTVT $21.40
- Average True Range (ATR)
- CPIX 0.20
- VTVT 1.20
- MACD
- CPIX -0.01
- VTVT 0.32
- Stochastic Oscillator
- CPIX 4.17
- VTVT 92.81
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.